Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Med Clin North Am. 2018 Jul;102(4):621–634. doi: 10.1016/j.mcna.2018.02.005

Table 1.

Patient groups to consider for naloxone prescribing, by guidelines

CDC9 Veterans Affairs/Department of Defense7 Canadian8
  • Prescribed doses of greater or equal to 50-mg morphine equivalents

  • Personal history of previous overdose

  • History of substance use disorder or concurrent use of benzodiazepines

  • Relatives of family members with OUD in states where third party prescribing is allowed

  • Starting chronic opioid therapy

  • Tapering or have recently discontinued opioid therapy

  • High-dose opioid therapy

  • Comorbidities

  • During opioid rotation

  • OUD

  • Recreational opioid use

  • Intravenous drug use